Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 6 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Jan. 22, 2019 CDNA M 5,000 · · 25,000 Direct -16.67% Disposed (price as of 2026-10-02)
Jan. 22, 2019 CDNA M 5,000 $12.88 $64,400 15,837 Direct +46.14% Acquired 421.4% (price as of 2026-10-02)
Jan. 2, 2019 CDNA A 437 · · 10,837 Direct +4.20% Acquired (price as of 2026-10-02)
Oct. 1, 2018 CDNA A 400 · · 10,400 Direct +4.00% Acquired (price as of 2026-10-02)
July 1, 2018 CDNA A 30,000 · · 30,000 Direct · Acquired (price as of 2026-10-02)
July 1, 2018 CDNA A 10,000 · · 10,000 Direct · Acquired (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Jan. 22, 2019 CDNA Stock Option (right to buy) Common Stock (5,000) $12.88 July 1, 2028 5,000 Disposed
July 1, 2018 CDNA Stock Option (right to buy) Common Stock (30,000) $12.88 July 1, 2028 30,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).